Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GBT009 for Scar Improvement After Breast Reconstruction
NCT01053897Phase 2Completed
- Sponsor
- Garnet BioTherapeutics, Inc.
- Start
- Jan 2010
- Primary completion
- Oct 2011
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of GBT009 in scar, sponsored by Garnet BioTherapeutics, Inc.. Started Jan 2010; status: completed.
02
Drugs
GBT009
03
Conditions
scar
Beyond the preview
Go deeper on NCT01053897.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01053897.